May 16, 2022

Vestaron raises $82M in investment round

Vestaron recently closed Series C fundraising efforts, bringing in $82 million from new and existing investors at the peptide-based biological crop protection company.

Lead investors include Ordway Selections and Cavallo Ventures. Argonautic Ventures, Fortistar and Endeavor8 are also participating.

“The efficacy of Vestaron’s products, the company’s scalable manufacturing processes and the involvement of some of the leading strategic and financial investors allows Ordway Selections to confidently state that Vestaron is at an inflection point,” Ariel Barack, head of food and agriculture at Ordway Selections, said in a news release.

Vestaron welcomes returning investors: Novo Holdings, Northpond Ventures, CGC Ventures, iSelect and Syngenta Ventures.

“Vestaron has developed groundbreaking peptide technology with a successful commercial launch in the agricultural industry,” Craig Herron, managing partner at iSelect, said in the release. “We are excited to have a hand in the revolution in this early stage.”

Barack, Herron and Mike Wilbur, from Cavallo Ventures, are joining Vestaron’s board of directors as board observers.

“With the caliber of additional investors, our recently added board of directors, Randy Papadellis and audit chair Susan Altschuller, Vestaron is primed for a strong and dynamic future,” Vestaron CEO Anna Rath said in the release.

About Vestaron Corp.

Vestaron provides growers with effective peptide-based biopesticides that overcome existing resistance issues while offering a desired safety profile for workers, beneficials and the environment. Vestaron has earned global recognition for its work, including the inaugural 2015 Bernard Blum Award for novel biocontrol solutions, the Green Chemistry Challenge Award from the U.S. Environmental Protection Agency, and the American Chemical Society Green Chemistry Institute in 2020, and Best New Biologic Product in the 2021 Crop Science Awards.

For more information, visit www.vestaron.com